Founder & CEO, Propel Biologics
Propel Biologics™ JetCAP™: Revolutionary Oral Delivery Technology
The JetCAP™ oral capsule device offers a needle-free fluid dynamics solution to deliver payload into or onto the wall of the gut for both topical gut delivery and systemic bioavailability.
With a liquid reservoir up to 0.3 ml, JetCAP™ offers high drug delivery capacity with the flexibility of solution and suspension formulations.
Dr. Rhodes founded DDE Labs in 2014 after 4 years of consulting and 20 years in pharmaceutical, biotechnology, and drug delivery companies, where he held both technical and executive leadership roles. He has extensive experience translating molecular therapeutics, formulation, delivery, and device programs from late stage research into clinical development.